Last updated: August 17, 2026

Examiner: BLUMEL, BENJAMIN P

Tech Center 1600 • Art Units: 1600 1648 1671

This examiner grants 71% of resolved cases

Performance Statistics

70.7%

Allow Rate

+10.7% vs TC avg

1,080

Total Applications

+30.6%

Interview Lift

1154

Avg Prosecution Days

Based on 1037 resolved cases, 2023–2026

5.8%

§101 Eligibility

14.8%

§102 Novelty

32.4%

§103 Obviousness

29.4%

§112 Clarity

App #	Title	Status	Assignee
18547976	EXTRACELLULAR VESICLE-BASED NANOCARRIERS	Non-Final OA	OHIO STATE INNOVATION FOUNDATION
18166743	MANNOSE CONJUGATED CHITOSAN-BASED INFLUENZA NANOVACCINE FORMULATIONS AND USES THEREOF	Final Rejection	Ohio State Innovation Foundation
18643793	MOLECULAR VACCINES FOR INFECTIOUS DISEASE	Non-Final OA	Agilent Technologies, Inc.
18076315	OMICRON SARS-COV-2 ASSAY	Final Rejection	Board of Regents, The University of Texas System
17760180	POLYPEPTIDES AND THEIR USE	Final Rejection	University of Washington

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.